MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.02.007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Kinga Czarnecka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland. Electronic address: ki…. Hauptthemen laut MEDLINE: Liver Transplantation, Metabolic Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Warsaw.
Abstract (Originalsprache)
BACKGROUND: Metabolic complications are a recognized health concern in liver transplant recipients that result in inferior patient-reported outcomes. Patients with MASH are known to be disproportionately affected by metabolic diseases compared to other indications for transplantation. PURPOSE: The aim of this study was to investigate the incidence of metabolic abnormalities in liver recipients with specific focus on differences between patients transplanted for MASH and non-MASH-causes. PATIENTS AND METHODS: An observational, monocentric, and retrospective analysis was performed. Patients who received a cadaveric-donor-liver transplant between 2010 and 2019 were eligible. RESULTS: 282 patients were enrolled with a median age of 52 years (66.7% males). Metabolic dysfunction-associated steatohepatitis (MASH) led to liver transplant in 8.2% of cases. De-novo metabolic syndrome was diagnosed in 36% of the study population. Patients that underwent transplant owing to MASH showed significantly higher incidence of metabolic complications in both pre- and post-transplant period. Considerable differences were noted in the pattern of weight gain between patients transplanted for MASH and non-MASH patients. The MASH etiology (OR: 5.5; 95% CI: 1.624-22.868; P = .010), higher BMI at 1-year post-transplant (OR: 1.321; 95% CI: 1.214-1.449; P =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland. Electronic address: kinga.czarnecka@wum.edu.pl.
- Department of Transplant Medicine, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Förderung
- Medical University of Warsaw
Zitieren
APA
Czarnecka, K., Czarnecka, P., Tronina, O., Bączkowska, T., & Durlik, M. (2024). MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.02.007
Vancouver
Czarnecka K, Czarnecka P, Tronina O, Bączkowska T, Durlik M. MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.02.007
BibTeX
@article{Czarnecka2024,
author = {Czarnecka, Kinga and Czarnecka, Paulina and Tronina, Olga and Bączkowska, Teresa and Durlik, Magdalena},
title = {MASH Continues as a Significant Burden on Metabolic Health of Liver Recipients},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.02.007}
}
EUVIMED